Successful treatment of myasthenia gravis with tacrolimus

• Amelia Evoli

• Chiara Di Schino

• Francesca Marsili

• Chiara Punzi

抄録

Tacrolimus (FK‐506) is a calcium‐calcineurin inhibitor, successfully used in transplant recipients. We report the successful use of tacrolimus as a single immunosuppressant in a patient who had developed myasthenia gravis (MG) during interferon alpha treatment. In this case, the coexistence of hepatitis C and type 2 diabetes mellitus contraindicated the use of both steroids and azathioprine, and cyclosporine A, although effective, had induced renal failure. Tacrolimus proved to be effective in the treatment of MG, was not significantly hepatotoxic, and was less nephrotoxic than cyclosporine. © 2002 John Wiley & Sons, Inc. Muscle Nerve 25: 111–114, 2002

収録刊行物

• Muscle & Nerve

  Muscle & Nerve 25 (1), 111-114, 2001-12-19

  Wiley

キーワード

• Physiology (medical)
• Cellular and Molecular Neuroscience
• Neurology (clinical)
• Physiology

詳細情報

• CRID: 1363951793722219648
• NII論文ID: 30004646057
• DOI: 10.1002/mus.10018
• ISSN: 10974598
• ISSN: 0148639X
• ISSN: http://id.crossref.org/issn/0148639X
• Web Site: https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fmus.10018
• Web Site: https://onlinelibrary.wiley.com/doi/pdf/10.1002/mus.10018
• データソース種別:
  • Crossref
  • CiNii Articles